1. Should be NICE have a Spanish NICE?

   • J. Feliu
   • E. Espinosa

   Editorial 06 June 2013 Pages: 501 - 502

2. Lung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkers

   • E. Conde
   • B. Angulo
   • F. López-Ríos

   Educational Series - Blue Series Open access 29 January 2013 Pages: 503 - 508

   

3. GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012

   • A. González Martín
   • A. Redondo
   • A. Poveda Velasco

   Educational Series - Red Series Open access 07 March 2013 Pages: 509 - 525

   

4. Optimal management of breakthrough cancer pain (BCP)

   • Y. Escobar
   • A. Mañas
   • J. J. Cruz

   Review Article 21 December 2012 Pages: 526 - 534

   

5. Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis

   • T. Korkmaz
   • S. Seber
   • N. S. Turhal

   Research Article 10 November 2012 Pages: 535 - 540

   

6. Increased expression of CD24 is associated with tumor progression and prognosis in patients suffering osteosarcoma

   • J. Tang
   • H. Cai
   • M. Tang

   Research Article 10 November 2012 Pages: 541 - 547

   

7. Management and outcome of ovarian malignancy complicating pregnancy: an analysis of 41 cases and review of the literature

   • T. Gui
   • D. Cao
   • X. Liu

   Research Article 13 November 2012 Pages: 548 - 554

8. Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer

   • Tarique N. Hasan
   • B. Leena Grace
   • Rabbani Syed

   Research Article 21 December 2012 Pages: 555 - 562

   

9. Altered expression of piRNAs and their relation with clinicopathologic features of breast cancer

   • G. Huang
   • H. Hu
   • X. Zhang

   Research Article 15 November 2012 Pages: 563 - 568

   

10. Upregulation of microRNA-224 confers a poor prognosis in glioma patients

    • S. Lu
    • S. Wang
    • B. Jiao

    Research Article 21 December 2012 Pages: 569 - 574

    

11. Persistent elevated C-reactive protein after treatment is an independent marker of a poor prognosis in patients with hepatocellular carcinoma

    • N. Imai
    • A. Kinoshita
    • H. Tajiri

    Research Article 21 December 2012 Pages: 575 - 581

    

12. Lack of Bax expression is associated with irinotecan-based treatment activity in advanced colorectal cancer patients

    • F. Pietrantonio
    • P. Biondani
    • M. Di Bartolomeo

    Brief Research Article 21 November 2012 Pages: 582 - 586